Quantum BioPharma Ltd. (QNTM) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
55 University Ave.
Toronto, ON M5J 2H7
Canada
Phone
+1 416 854 8884
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
17
First IPO Date
June 08, 2018
| Name | Title | Pay | Year Born |
| Zeeshan Saeed | Co-Founder, Chief Executive Officer, & Executive Non-Independent Co-Chairman | 429,419 | 1970 |
| Nathan Coyle | Controller | 92,091 | 1981 |
| Ashwini Joshi | Director of Pharmaceutical Development | 113,631 | N/A |
| Andrzej Chruscinski | Vice President of Clinical & Scientific Affairs | 162,827 | N/A |
| Donal Carroll | Chief Financial Officer | 429,419 | 1977 |
| Anthony John Durkacz | Co-Founder & Executive Non-Independent Co-Chairman | 429,419 | 1976 |
| Maryann Adesso | Corporate Secretary | 0 | N/A |
| Patrick Onyango | Director of Operations at U.S. | 0 | N/A |
| Jason D. Sawyer | Head of Finance & Mergers and Acquisitions | 0 | 1972 |
| Lakshmi Kotra | President & Director | 0 | 1971 |
| Randell Mack | President of FSD BioSciences | 0 | N/A |
Quantum BioPharma Ltd., a biopharmaceutical firm headquartered in Toronto, Canada, is dedicated to the discovery and advancement of biotechnological solutions and drug candidates. The company focuses on addressing complex neurodegenerative, inflammatory, and metabolic conditions, alongside alcohol use disorder, with its pipeline featuring a range of drug candidates at varying stages of development. Its operations are divided into two main divisions: its core biopharmaceutical activities and strategic investment holdings. A flagship asset is Lucid-MS, a novel, proprietary chemical entity currently in Phase 2 clinical trials. Preclinical data indicates its potential to prevent and reverse the degradation of myelin, a key process underlying multiple sclerosis. Furthermore, Quantum BioPharma is developing a therapeutic solution for alcohol addiction, intended for application in hospital and clinical environments. The company's strategic investments portfolio includes various loans collateralized by residential real estate. Previously known as FSD Pharma Inc., the company adopted its current name, Quantum BioPharma Ltd., in August 2024.